The object of the present invention is a novel formulation, based on Prostate Specific Membrane Antigen (PSMA) ligands, for use as radiopharmaceutical precursors (kold kits). The formulation of the invention is designed to allow the radiopharmaceutical to be prepared instantaneously and in a single step by direct addition of radioactive isotopes, to be used both for diagnostic and therapeutic purposes.
COLD KITS BASED ON PSMA LIGANDS FOR THE PREPARATION OF RADIOPHARMACEUTICALS
Denora N.
;Laquintana V.
;Lopedota A. A.
;Lopalco A.
;Altomare C. D.
;Iacobazzi R. M.
;Ghafir El Idrissi I.
2022-01-01
Abstract
The object of the present invention is a novel formulation, based on Prostate Specific Membrane Antigen (PSMA) ligands, for use as radiopharmaceutical precursors (kold kits). The formulation of the invention is designed to allow the radiopharmaceutical to be prepared instantaneously and in a single step by direct addition of radioactive isotopes, to be used both for diagnostic and therapeutic purposes.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
